Invivyd (IVVD) director receives 50,000 options at $1.04 strike price

Rhea-AI Filing Summary

Invivyd, Inc. reported that director Marc Elia received a grant of stock options covering 50,000 shares of common stock at an exercise price of $1.04 per share. The options vest in full on the earlier of May 19, 2027 or the company’s 2027 Annual Meeting of Stockholders, subject to his continuous service, and expire on May 18, 2036. Following this award, Elia holds 50,000 stock options, which he is deemed to hold for the benefit of M28 Capital Management LP and funds managed by that firm.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Elia Marc, M28 Capital Management LP

Role null | null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	50,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 50,000 options Exercise price: $1.04 per share Expiration date: May 18, 2036 +3 more

6 metrics

Option grant size 50,000 options Stock Option (Right to Buy) granted to director

Exercise price $1.04 per share Conversion or exercise price of stock options

Expiration date May 18, 2036 Option term end for the grant

Vesting latest date May 19, 2027 Options vest by earlier of this date or 2027 annual meeting

Post-grant derivative holdings 50,000 options Total stock options held following the transaction

Grant price $0.00 Options granted as compensation with no cash paid at grant

Key Terms

Stock Option (Right to Buy), exercise price, expiration date, Annual Meeting of Stockholders

4 terms

Stock Option (Right to Buy) financial

"security title listed as "Stock Option (Right to Buy)" for the grant"

exercise price financial

"conversion or exercise price of 1.0400 per share for the options"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration date specified as 2036-05-18 for the stock option grant"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Annual Meeting of Stockholders financial

"vesting occurs by the date of the Issuer's 2027 Annual Meeting of Stockholders"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elia Marc

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.04	05/19/2026		A		50,000		(1)	05/18/2036	Common Stock	50,000	$0	50,000	D

1. Name and Address of Reporting Person^*

Elia Marc

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			See Remarks

1. Name and Address of Reporting Person^*

M28 Capital Management LP

(Last) (First) (Middle)

700 CANAL STREET

2ND FLOOR

(Street)

STAMFORD CONNECTICUT 06902

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			See Remarks

Explanation of Responses:

1. This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. The grant was awarded to Marc Elia ("Mr. Elia"). Mr. Elia is deemed to hold the grant for the benefit of M28 Capital Management LP ("M28 Capital Management") and the funds managed by M28 Capital Management.

Remarks:

M28 Capital Management may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Mr. Elia, who indirectly controls M28 Capital Management, currently serves on the board of directors of the Issuer. The Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.

	/s/ Jill Andersen attorney-in-fact for Marc Elia	05/21/2026
	M28 Capital Management LP, By: /s/ Marc Elia	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Invivyd (IVVD) disclose for Marc Elia?

Invivyd disclosed that director Marc Elia received a grant of 50,000 stock options. These options allow him to buy common shares at a fixed $1.04 exercise price, serving as equity-based compensation linked to his ongoing service with the company.

What are the key terms of Marc Elia’s 50,000 Invivyd (IVVD) stock options?

The grant covers 50,000 options with a $1.04 exercise price and a May 18, 2036 expiration. The options vest in full on the earlier of May 19, 2027 or Invivyd’s 2027 Annual Meeting of Stockholders, assuming continuous service until that vesting date.

When do Marc Elia’s Invivyd (IVVD) stock options vest?

The options vest in full on the earlier of May 19, 2027 or Invivyd’s 2027 Annual Meeting of Stockholders. Vesting is conditioned on Marc Elia’s continuous service with the company through that date, aligning his incentives with longer-term board service.

What is the exercise price and expiration date of the Invivyd (IVVD) options granted?

The stock options have an exercise price of $1.04 per share and expire on May 18, 2036. This gives a long-dated right to purchase Invivyd common shares at that fixed price once the options are vested and exercisable.

Who ultimately benefits from Marc Elia’s Invivyd (IVVD) option grant?

The grant was awarded to Marc Elia but is deemed held for the benefit of M28 Capital Management LP and the funds it manages. This means economic benefits from the options are intended for those investment entities rather than solely for Elia personally.